<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A rational, multidisciplinary approach to <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and the non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> has been responsible for major advances in therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Invasive diagnostic procedures and exploratory laparotomy, with their associated complications, make nontraumatic radionuclide imaging most appealing in both the clinical staging of disease and in evaluating therapy </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="29" ids="49631">Gallium</z:chebi>-67-<z:chebi fb="2" ids="50744">citrate</z:chebi>, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> scanning agent of the early 1970's, has demonstrated a marked affinity for <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and the other <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>False positives are few, with sensitivity greater than 70% throughout the spectrum of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and the histiocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition to confirming sites of suspected <z:hpo ids='HP_0002664'>neoplasm</z:hpo>, this agent has proved useful in the detection of occult involvement </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, resolution of abnormal <z:chebi fb="29" ids="49631">gallium</z:chebi>-67 concentrations on follow-up studies functions as a visual ancillary index of therapeutic response </plain></SENT>
<SENT sid="6" pm="."><plain>The value of wholebody <z:chebi fb="29" ids="49631">gallium</z:chebi>-67 scintigraphy is further enhanced when used in conjunction with routine <z:chebi fb="1" ids="33353">technetium</z:chebi> brain, bone, liver, and spleen scans </plain></SENT>
<SENT sid="7" pm="."><plain>While the diagnostic accuracy of <z:chebi fb="29" ids="49631">gallium</z:chebi>-67 studies has been limited in the abdomen due to bowel activity, our attempts to improve these results with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-seeking radiopharmaceutical <z:chebi fb="1" ids="30430">indium</z:chebi>-111-<z:chebi fb="0" ids="3139">Bleomycin</z:chebi> were unrewarding and subsequently were discontinued </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, radionuclide lymphography has also been explored </plain></SENT>
<SENT sid="9" pm="."><plain>Its diagnostic usefulness in detecting pelvic and abdominal lymph node involvement warrants further investigation </plain></SENT>
</text></document>